Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00016445 · ClinicalTrials.gov registry record · Phase 2
Phase II Study of Growth Hormone in Children With Cystic Fibrosis
A Phase 2 study of Cystic Fibrosis, sponsored by University of Utah.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 9
- Study locations
NCT00016445: Completed Phase 2 study of Cystic Fibrosis, sponsored by University of Utah.
NCT00016445 is a Phase 2 study of Cystic Fibrosis that has completed, run by University of Utah. The registered enrollment target is 40 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (78% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00016445, a Phase 2 study of Cystic Fibrosis, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 9
- Study locations
Study Summary
OBJECTIVES: I. Determine the effect of growth hormone on height, height velocity, body weight, and lean body mass in patients with cystic fibrosis. II. Determine the effect of growth hormone on pulmonary function in these patients. III. Determine the impact of this drug on the quality of life in these patients. IV. Determine if the clinical response from this drug is sustained in these patients.
Conditions Studied
Interventions
- DRUG growth hormone
Study Locations (9)
Texas
- Southwest Medical Center at Dallas - Dallas
- Cook Children's Medical Center - Fort Worth - Fort Worth
Arizona
- Phoenix Children's Hospital - Phoenix
California
- Children's Hospital of Orange County - Orange
Indiana
- James Whitcomb Riley Hospital for Children - Indianapolis
Missouri
- Washington University - St Louis
Ohio
- Children's Medical Center - Dayton - Dayton
Oklahoma
- T.L. Carey, M.D. and Associates - Tulsa
Utah
- Primary Children's Medical Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2001-02 |
| Phase | Phase 2 |
What the finished NCT00016445 record still lists
NCT00016445 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which growth hormone is the first listed.
NCT00016445 lists 9 locations in 8 states (Texas, Arizona, California).
Frequently Asked Questions
What is clinical trial NCT00016445 about?
NCT00016445 is a clinical study titled "Phase II Study of Growth Hormone in Children With Cystic Fibrosis". OBJECTIVES: I. Determine the effect of growth hormone on height, height velocity, body weight, and lean body mass in patients with cystic fibrosis. II. Determine the effect of growth hormone on pulmonary function in these patients. III. Determine the impact of this drug on the quality of life in t...
What is the current status of trial NCT00016445?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2001-02.
What conditions does trial NCT00016445 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
What interventions are being tested in trial NCT00016445?
The interventions under investigation include: growth hormone (DRUG).
Who is sponsoring clinical trial NCT00016445?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00016445 being conducted?
This trial has 9 study locations across Arizona, California, Indiana, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00016445's enrollment target sits among peer trials
40 100th of 169 higher than 66 of 169 other Cystic Fibrosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cystic Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RECRUITING · Phase 2
-
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
RECRUITING · Phase 2
-
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients with Cystic Fibrosis
RECRUITING · Phase 2
-
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
RECRUITING · Phase 2
-
A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
RECRUITING · Phase 2
-
SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia